Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Hepatitis

  Free Subscription


Articles published in J Med Virol

Retrieve available abstracts of 165 articles:
HTML format
Text format



Single Articles


    March 2012
  1. CHAILLON A , Schnepf N, Jonas M, Mondon K, et al
    Case report: Benefits of quantitative polymerase chain reaction in the clinical management of herpes simplex virus 1 infection with prominent hepatitis and unusual secondary progression.
    J Med Virol. 2012;84:457-61.
    PubMed     Text format     Related articles    Abstract available



  2. SHEN L , Gu Y, Sun L, Yang Y, et al
    Development of a hepatitis delta virus antibody assay for study of the prevalence of HDV among individuals infected with hepatitis B virus in China.
    J Med Virol. 2012;84:445-9.
    PubMed     Text format     Related articles    Abstract available



  3. HAYASHI K , Katano Y, Kuzuya T, Tachi Y, et al
    Prevalence of hepatitis C virus genotype 1a in Japan and correlation of mutations in the NS5A region and single-nucleotide polymorphism of interleukin-28B with the response to combination therapy with pegylated-interferon-alpha 2b and ribavirin.
    J Med Virol. 2012;84:438-44.
    PubMed     Text format     Related articles    Abstract available



  4. CHARY A , Winters MA, Eisen R, Knight TH, et al
    Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/HCV-coinfection.
    J Med Virol. 2012;84:431-7.
    PubMed     Text format     Related articles    Abstract available



  5. YANG HJ , Lee JH, Kim YJ, Yoon JH, et al
    Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance.
    J Med Virol. 2012;84:424-30.
    PubMed     Text format     Related articles    Abstract available



  6. MOHEBBI SR , Amini-Bavil-Olyaee S, Zali N, Damavand B, et al
    Characterization of hepatitis B virus genome variability in Iranian patients with chronic infection, a nationwide study.
    J Med Virol. 2012;84:414-23.
    PubMed     Text format     Related articles    Abstract available



    February 2012
  7. BLACKARD JT , Ma G, Welge JA, Martin CM, et al
    Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization.
    J Med Virol. 2012;84:242-52.
    PubMed     Text format     Related articles    Abstract available



  8. SHAH DP , Grimes CZ, Brown E, Hwang LY, et al
    Demographics, socio-behavioral factors, and drug use patterns: What matters in spontaneous HCV clearance?
    J Med Virol. 2012;84:235-41.
    PubMed     Text format     Related articles    Abstract available



  9. SASAYAMA M , Shoji I, Adianti M, Jiang DP, et al
    A point mutation at Asn-534 that disrupts a conserved N-glycosylation motif of the E2 glycoprotein of hepatitis C virus markedly enhances the sensitivity to antibody neutralization.
    J Med Virol. 2012;84:229-34.
    PubMed     Text format     Related articles    Abstract available



  10. KARATAPANIS S , Tsoplou P, Papastergiou V, Vasiageorgi A, et al
    Hepatitis C virus genotyping in Greece: Unexpected high prevalence of genotype 5a in a Greek island.
    J Med Virol. 2012;84:223-8.
    PubMed     Text format     Related articles    Abstract available



  11. LEE SH , Kim HS, Byun IS, Jeong SW, et al
    Pre-existing YMDD mutants in treatment-naive patients with chronic hepatitis B are not selected during lamivudine therapy.
    J Med Virol. 2012;84:217-22.
    PubMed     Text format     Related articles    Abstract available



  12. LI XG , Liu BM, Xu J, Liu XE, et al
    Discrepancy of potential antiviral resistance mutation profiles within the HBV reverse transcriptase between nucleos(t)ide analogue-untreated and -treated patients with chronic hepatitis B in a hospital in China.
    J Med Virol. 2012;84:207-16.
    PubMed     Text format     Related articles    Abstract available



  13. MA Q , Wang Y
    Comprehensive analysis of the prevalence of hepatitis B virus escape mutations in the major hydrophilic region of surface antigen.
    J Med Virol. 2012;84:198-206.
    PubMed     Text format     Related articles    Abstract available



    January 2012
  14. FOGEDA M , Avellon A, Echevarria JM
    Prevalence of specific antibody to hepatitis E virus in the general population of the community of Madrid, Spain.
    J Med Virol. 2012;84:71-4.
    PubMed     Text format     Related articles    Abstract available



  15. TOYODA H , Kumada T, Tada T, Hayashi K, et al
    Predictive value of early viral dynamics during peginterferon and ribavirin combination therapy based on genetic polymorphisms near the IL28B gene in patients infected with HCV genotype 1b.
    J Med Virol. 2012;84:61-70.
    PubMed     Text format     Related articles    Abstract available



  16. SILVA GF , Grotto RM, Verdichio-Moraes CF, Corvino SM, et al
    Human platelet antigen genotype is associated with progression of fibrosis in chronic hepatitis C.
    J Med Virol. 2012;84:56-60.
    PubMed     Text format     Related articles    Abstract available



  17. HERIYANTO DS , Yano Y, Utsumi T, Anggorowati N, et al
    Mutations within enhancer II and BCP regions of hepatitis B virus in relation to advanced liver diseases in patients infected with subgenotype B3 in Indonesia.
    J Med Virol. 2012;84:44-51.
    PubMed     Text format     Related articles    Abstract available



  18. SAGOE KW , Agyei AA, Ziga F, Lartey M, et al
    Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naive patients with HIV infection at a major treatment center in Ghana.
    J Med Virol. 2012;84:6-10.
    PubMed     Text format     Related articles    Abstract available



    December 2011
  19. DEMETRIOU VL , Kostrikis LG
    Near-full genome characterization of unclassified hepatitis c virus strains relating to genotypes 1 and 4.
    J Med Virol. 2011;83:2119-27.
    PubMed     Text format     Related articles    Abstract available



  20. NJOUOM R , Lavoie M, Foupouapouognigni Y, Frost E, et al
    Transmission of Hepatitis C virus among spouses in Cameroon and the Central African Republic.
    J Med Virol. 2011;83:2113-8.
    PubMed     Text format     Related articles    Abstract available



  21. REIS LM , Soares MA, Franca PH, Soares EA, et al
    Clonal analysis of hepatitis B viruses among blood donors from Joinville, Brazil: Evidence of dual infections, intragenotype recombination and markers of risk for hepatocellular carcinoma.
    J Med Virol. 2011;83:2103-12.
    PubMed     Text format     Related articles    Abstract available



  22. EZZIKOURI S , Rebbani K, Mostafa A, El Feydi AE, et al
    Influence of mutation of the HFE gene on the progression of chronic viral hepatitis B and C in Moroccan patients.
    J Med Virol. 2011;83:2096-102.
    PubMed     Text format     Related articles    Abstract available



  23. RYU HJ , Kim do Y, Park JY, Chang HY, et al
    Clinical features and prognosis of hepatocellular carcinoma with respect to pre-S deletion and basal core promoter mutations of hepatitis B virus Genotype C2.
    J Med Virol. 2011;83:2088-95.
    PubMed     Text format     Related articles    Abstract available



  24. KIM D , Lyoo KS, Smith D, Hur W, et al
    Number of mutations within CTL-defined epitopes of the hepatitis B Virus (HBV) core region is associated with HBV disease progression.
    J Med Virol. 2011;83:2082-7.
    PubMed     Text format     Related articles    Abstract available



  25. YUN H , Lee HJ, Jang JH, Kim JS, et al
    Hepatitis A Virus genotype and its correlation with the clinical outcome of acute hepatitis A in Korea: 2006-2008.
    J Med Virol. 2011;83:2073-81.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  26. VAN DAMME P , Leroux-Roels G, Crasta P, Messier M, et al
    Antibody persistence and immune memory in adults, 15 years after a three-dose schedule of a combined hepatitis A and B vaccine.
    J Med Virol. 2011 Nov 3. doi: 10.1002/jmv.22264.
    PubMed     Text format     Related articles    Abstract available



  27. HU JL , Cui J, Guo JJ, Zhang WL, et al
    Phenotypic assay of a hepatitis B virus strain carrying an rtS246T variant using a new strategy.
    J Med Virol. 2011 Nov 3. doi: 10.1002/jmv.22260.
    PubMed     Text format     Related articles    Abstract available



  28. GASIM GI , Hamdan HZ, Hamdan SZ, Adam I, et al
    Epidemiology of hepatitis B and hepatitis C virus infections among hemodialysis patients in Khartoum, Sudan.
    J Med Virol. 2011 Nov 3. doi: 10.1002/jmv.22256.
    PubMed     Text format     Related articles    Abstract available



  29. PAN L , Zhang W, Liang Z, Wu X, et al
    Association between polymorphisms of the cytokine and cytokine receptor genes and immune response to hepatitis B vaccination in a Chinese Han population.
    J Med Virol. 2011 Nov 3. doi: 10.1002/jmv.22251.
    PubMed     Text format     Related articles    Abstract available



  30. WU S , Liu Y, Cheng L, Yin B, et al
    Clinical evaluation of the signal-to-cutoff ratios of hepatitis C virus antibody screening tests used in China.
    J Med Virol. 2011;83:1930-7.
    PubMed     Text format     Related articles    Abstract available



  31. FURUI Y , Hoshi Y, Murata K, Ito K, et al
    Prevalence of Amino acid mutation in hepatitis C virus core region among Japanese volunteer blood donors.
    J Med Virol. 2011;83:1924-9.
    PubMed     Text format     Related articles    Abstract available



  32. HANSEN BE , Rijckborst V, Ter Borg MJ, Janssen HL, et al
    HBV DNA suppression in HBeAg-positive chronic hepatitis B patients treated with peginterferon or placebo.
    J Med Virol. 2011;83:1917-23.
    PubMed     Text format     Related articles    Abstract available



  33. COPPOLA N , Tonziello G, Pisaturo M, Messina V, et al
    Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings.
    J Med Virol. 2011;83:1909-16.
    PubMed     Text format     Related articles    Abstract available



  34. TARAMASSO L , Caligiuri P, Di Biagio A, Bruzzone B, et al
    Lamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis B.
    J Med Virol. 2011;83:1905-8.
    PubMed     Text format     Related articles    Abstract available



  35. FUNG J , Lai CL, Young J, Wong DK, et al
    Stability of hepatitis B surface antigen over time: Implications for studies using stored sera.
    J Med Virol. 2011;83:1900-4.
    PubMed     Text format     Related articles    Abstract available



  36. PASAJE CF , Kim JH, Park BL, Cheong HS, et al
    Lack of association of RAD51 genetic variations with hepatitis B virus clearance and occurrence of hepatocellular carcinoma in a Korean population.
    J Med Virol. 2011;83:1892-9.
    PubMed     Text format     Related articles    Abstract available



  37. VAN HERCK K , Jacquet JM, Van Damme P
    Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: Long-term follow-up at 15 years.
    J Med Virol. 2011;83:1885-91.
    PubMed     Text format     Related articles    Abstract available



  38. POURKARIM MR , Lemey P, Amini-Bavil-Olyaee S, Houspie L, et al
    Molecular characterization of hepatitis B virus strains circulating in Belgian patients co-infected with HIV and HBV: Overt and occult infection.
    J Med Virol. 2011;83:1876-84.
    PubMed     Text format     Related articles    Abstract available



    October 2011
  39. KIM SS , Cheong JY, Lee D, Lee MH, et al
    Adefovir-based combination therapy with entecavir or lamivudine for patients with entecavir-refractory chronic hepatitis B.
    J Med Virol. 2011 Oct 25. doi: 10.1002/jmv.22227.
    PubMed     Text format     Related articles    Abstract available



  40. DAI S , Shen Z, Zha Z, Leng R, et al
    Seroprevalence of HIV, syphilis, and hepatitis C virus in the general population of the Liangshan Prefecture, Sichuan Province, China.
    J Med Virol. 2011 Oct 25. doi: 10.1002/jmv.22214.
    PubMed     Text format     Related articles    Abstract available



  41. FERREIRA AD , Perez RD, Ferraz ML, Lewis-Ximenez LL, et al
    Acute hepatitis C in Brazil: Results of a national survey.
    J Med Virol. 2011;83:1738-1743.
    PubMed     Text format     Related articles    Abstract available



  42. YOKOZAKI S , Katano Y, Hayashi K, Ishigami M, et al
    Mutations in two PKR-binding domains in chronic hepatitis C of genotype 3a and correlation with viral loads and interferon responsiveness.
    J Med Virol. 2011;83:1727-32.
    PubMed     Text format     Related articles    Abstract available



  43. UTAMA A , Siburian MD, Fanany I, Intan MD, et al
    Low prevalence of hepatitis B virus pre-s deletion mutation in Indonesia.
    J Med Virol. 2011;83:1717-26.
    PubMed     Text format     Related articles    Abstract available



  44. KABA M , Richet H, Ravaux I, Moreau J, et al
    Hepatitis E virus infection in patients infected with the human immunodeficiency virus.
    J Med Virol. 2011;83:1704-16.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  45. CICCOZZI M , Zehender G, Cento V, Presti AL, et al
    Molecular analysis of hepatitis C virus infection in Bulgarian injecting drug users.
    J Med Virol. 2011;83:1565-70.
    PubMed     Text format     Related articles    Abstract available



  46. TOYODA H , Kumada T, Hayashi K, Honda T, et al
    Antiviral combination therapy with peginterferon and ribavirin does not induce a therapeutically resistant mutation in the HCV core region regardless of genetic polymorphism near the IL28B gene.
    J Med Virol. 2011;83:1559-64.
    PubMed     Text format     Related articles    Abstract available



  47. DAO DY , Balko J, Attar N, Neak E, et al
    Hepatitis B virus genotype G: Prevalence and impact in patients co-infected with human immunodeficiency virus.
    J Med Virol. 2011;83:1551-8.
    PubMed     Text format     Related articles    Abstract available



  48. XIAO L , Zhou B, Gao H, Ma S, et al
    Hepatitis B virus genotype B with G1896A and A1762T/G1764A mutations is associated with hepatitis B related acute-on-chronic liver failure.
    J Med Virol. 2011;83:1544-50.
    PubMed     Text format     Related articles    Abstract available



  49. LANDRUM ML , Roediger MP, Fieberg AM, Weintrob AC, et al
    Development of chronic hepatitis B virus infection in hepatitis B surface antigen negative HIV/HBV co-infected adults: A rare opportunistic illness.
    J Med Virol. 2011;83:1537-43.
    PubMed     Text format     Related articles    Abstract available



  50. VENEGAS M , Alvarado-Mora MV, Villanueva RA, Rebello Pinho JR, et al
    Phylogenetic analysis of hepatitis B virus genotype F complete genome sequences from Chilean patients with chronic infection.
    J Med Virol. 2011;83:1530-6.
    PubMed     Text format     Related articles    Abstract available



  51. VILLAR LM , de Oliveira JC, Cruz HM, Yoshida CF, et al
    Assessment of dried blood spot samples as a simple method for detection of hepatitis B virus markers.
    J Med Virol. 2011;83:1522-9.
    PubMed     Text format     Related articles    Abstract available



  52. CHU FY , Su FH, Cheng SH, Lin YS, et al
    Hepatitis B surface antigen confirmatory testing for diagnosis of hepatitis b virus infection in Taiwan.
    J Med Virol. 2011;83:1514-21.
    PubMed     Text format     Related articles    Abstract available



  53. ABE H , Hayes CN, Ochi H, Tsuge M, et al
    Inverse association of IL28B genotype and liver mRNA expression of genes promoting or suppressing antiviral state.
    J Med Virol. 2011;83:1597-607.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  54. YAHOO N , Sabahi F, Shahzamani K, Malboobi MA, et al
    Mutations in the E2 and NS5A regions in patients infected with hepatitis C virus genotype 1a and their correlation with response to treatment.
    J Med Virol. 2011;83:1332-7.
    PubMed     Text format     Related articles    Abstract available



  55. NIEN HC , Sheu JC, Kao JH, Chou HC, et al
    Aboriginal Taiwanese hepatitis B carriers have more favorable viral factors than Han Chinese carriers.
    J Med Virol. 2011;83:1326-31.
    PubMed     Text format     Related articles    Abstract available



  56. COX LE , Arslan O, Allain JP
    Characterization of hepatitis B virus in turkish blood donors, and the prevalence of the SP1 splice variant.
    J Med Virol. 2011;83:1321-5.
    PubMed     Text format     Related articles    Abstract available



  57. YOON YK , Yeon JE, Kim JH, Sim HS, et al
    Comparative analysis of disease severity between genotypes IA and IIIA of hepatitis A virus.
    J Med Virol. 2011;83:1308-14.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  58. VEJBAESYA S , Nonnoi Y, Tanwandee T, Srinak D, et al
    Killer cell immunoglobulin-like receptors and response to antiviral treatment in Thai patients with chronic hepatitis C virus genotype 3a.
    J Med Virol. 2011 Jul 13. doi: 10.1002/jmv.22153.
    PubMed     Text format     Related articles    Abstract available



  59. ACKERMAN Z , Pappo O, Ben-Dov IZ
    The prognostic value of changes in serum ferritin levels during therapy for hepatitis C virus infection.
    J Med Virol. 2011;83:1262-8.
    PubMed     Text format     Related articles    Abstract available



  60. LIANG CC , Liu CH, Lin YL, Liu CJ, et al
    Functional impairment of dendritic cells in patients infected with hepatitis C virus genotype 1 who failed peginterferon plus ribavirin therapy.
    J Med Virol. 2011;83:1212-20.
    PubMed     Text format     Related articles    Abstract available



  61. TOYODA H , Kumada T, Tada T, Kawaguchi T, et al
    Impact of genetic polymorphisms near the IL28B gene and amino acid substitutions in the hepatitis C virus core region on interferon sensitivity/resistance in patients with chronic hepatitis C.
    J Med Virol. 2011;83:1203-11.
    PubMed     Text format     Related articles    Abstract available



  62. KIM JY , Won JE, Jeong SH, Park SJ, et al
    Acute hepatitis C in Korea: Different modes of infection, high rate of spontaneous recovery, and low rate of seroconversion.
    J Med Virol. 2011;83:1195-202.
    PubMed     Text format     Related articles    Abstract available



  63. CHAN DP , Lee SS, Lee KC
    The effects of widespread methadone treatment on the molecular epidemiology of hepatitis C virus infection among injection drug users in Hong Kong.
    J Med Virol. 2011;83:1187-94.
    PubMed     Text format     Related articles    Abstract available



  64. LEE MH , Lee da M, Kim SS, Cheong JY, et al
    Correlation of serum hepatitis B surface antigen level with response to entecavir in naive patients with chronic hepatitis B.
    J Med Virol. 2011;83:1178-86.
    PubMed     Text format     Related articles    Abstract available



  65. CHOLONGITAS E , Papatheodoridis GV, Manesis EK, Petraki K, et al
    Effect of antiviral therapy on the immunohistochemical expression of bcl-xL and bax protein in patients with HBeAg-negative chronic hepatitis B.
    J Med Virol. 2011;83:1165-71.
    PubMed     Text format     Related articles    Abstract available



  66. YANG RR , Gui X, Chen XY, Zhu Y, et al
    Interference of replication between hepatitis B and C viruses in patients infected with HIV.
    J Med Virol. 2011;83:1159-64.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  67. AKUTA N , Suzuki F, Hirakawa M, Kawamura Y, et al
    Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy.
    J Med Virol. 2011;83:1016-22.
    PubMed     Text format     Related articles    Abstract available



  68. PASCARELLA S , Clement S, Guilloux K, Conzelmann S, et al
    Effects of hepatitis C virus on suppressor of cytokine signaling mRNA levels: Comparison between different genotypes and core protein sequence analysis.
    J Med Virol. 2011;83:1005-15.
    PubMed     Text format     Related articles    Abstract available



  69. YAN T , Li K, Li F, Su H, et al
    T1846 and A/G1913 are associated with acute on chronic liver failure in patients infected with hepatitis B virus genotypes B and C.
    J Med Virol. 2011;83:996-1004.
    PubMed     Text format     Related articles    Abstract available



  70. BOKHARAEI-SALIM F , Keyvani H, Monavari SH, Alavian SM, et al
    Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease.
    J Med Virol. 2011;83:989-95.
    PubMed     Text format     Related articles    Abstract available



  71. HASHIMOTO Y , Ochi H, Abe H, Hayashida Y, et al
    Prediction of response to peginterferon-alfa-2b plus ribavirin therapy in Japanese patients infected with hepatitis C virus genotype 1b.
    J Med Virol. 2011;83:981-8.
    PubMed     Text format     Related articles    Abstract available



  72. IDILMAN R , Bozkus Y, Seval G, Mizrak D, et al
    Lymphoproliferative disorders in individuals with chronic hepatitis b and C in the Turkish population.
    J Med Virol. 2011;83:974-80.
    PubMed     Text format     Related articles    Abstract available



  73. GOBEL T , Erhardt A, Herwig M, Poremba C, et al
    High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe.
    J Med Virol. 2011;83:968-73.
    PubMed     Text format     Related articles   



  74. PANDE C , Sarin SK, Patra S, Bhutia K, et al
    Prevalence, risk factors and virological profile of chronic hepatitis b virus infection in pregnant women in India.
    J Med Virol. 2011;83:962-7.
    PubMed     Text format     Related articles    Abstract available



  75. AIZAWA M , Tsubota A, Fujise K, Tatsuzawa K, et al
    Clinical course and predictive factors of virological response in long-term lamivudine plus adefovir dipivoxil combination therapy for lamivudine-resistant chronic hepatitis B patients.
    J Med Virol. 2011;83:953-61.
    PubMed     Text format     Related articles    Abstract available



  76. GARMIRI P , Rezvan H, Abolghasemi H, Allain JP, et al
    Full genome characterization of hepatitis B virus strains from blood donors in Iran.
    J Med Virol. 2011;83:948-52.
    PubMed     Text format     Related articles    Abstract available



  77. TELAN EF , Samonte GM, Abellanosa-Tac-An IP, Alesna ET, et al
    The early phase of an HIV epidemic in a population exposed previously to HCV in the Philippines.
    J Med Virol. 2011;83:941-7.
    PubMed     Text format     Related articles    Abstract available



  78. BOLCIC F , Jones LR, Laufer N, Quarleri J, et al
    Molecular characterization of hepatitis C virus genotype 4 sequences in HIV-coinfected patients from Argentina.
    J Med Virol. 2011;83:935-40.
    PubMed     Text format     Related articles    Abstract available



  79. BARTH RE , Huijgen Q, Tempelman HA, Mudrikova T, et al
    Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa.
    J Med Virol. 2011;83:929-34.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  80. ROLFE KJ , Curran MD, Alexander GJ, Woodall T, et al
    Spontaneous loss of hepatitis C virus RNA from serum is associated with genotype 1 and younger age at exposure.
    J Med Virol. 2011 May 26. doi: 10.1002/jmv.22115.
    PubMed     Text format     Related articles    Abstract available



  81. DUAN L , Lei P, Yumei X, Xiaoping X, et al
    Prediction and identification-based prediction of Chinese hepatitis C Viral-specific cytotoxic T lymphocyte epitopes.
    J Med Virol. 2011 May 26. doi: 10.1002/jmv.22053.
    PubMed     Text format     Related articles    Abstract available



  82. KIM HS , Kim SJ, Park HW, Shin WG, et al
    Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
    J Med Virol. 2011 May 3. doi: 10.1002/jmv.22095.
    PubMed     Text format     Related articles   



  83. NAKAMUTA M , Fujino T, Yada R, Aoyagi Y, et al
    Expression profiles of genes associated with viral entry in HCV-infected human liver.
    J Med Virol. 2011;83:921-7.
    PubMed     Text format     Related articles    Abstract available



  84. MARTRO E , Valero A, Jordana-Lluch E, Saludes V, et al
    Hepatitis C virus sequences from different patients confirm the existence and transmissibility of subtype 2q, a rare subtype circulating in the metropolitan area of Barcelona, Spain.
    J Med Virol. 2011;83:820-6.
    PubMed     Text format     Related articles    Abstract available



  85. D'HEYGERE F , George C, Van Vlierberghe H, Decaestecker J, et al
    Efficacy of interferon-based antiviral therapy in patients with chronic hepatitis C infected with genotype 5: A meta-analysis of two large prospective clinical trials.
    J Med Virol. 2011;83:815-9.
    PubMed     Text format     Related articles    Abstract available



  86. KWON JH , Jeong SH, Kim JW, Bang SM, et al
    Case report: A case of light chain deposition disease involving liver and stomach with chronic hepatitis C virus infection and hepatocellular carcinoma.
    J Med Virol. 2011;83:810-4.
    PubMed     Text format     Related articles    Abstract available



  87. TAKANO T , Kohara M, Kasama Y, Nishimura T, et al
    Translocase of outer mitochondrial membrane 70 expression is induced by hepatitis C virus and is related to the apoptotic response.
    J Med Virol. 2011;83:801-9.
    PubMed     Text format     Related articles    Abstract available



  88. STABINSKI L , Reynolds SJ, Ocama P, Laeyendecker O, et al
    Hepatitis B virus and sexual behavior in Rakai, Uganda.
    J Med Virol. 2011;83:796-800.
    PubMed     Text format     Related articles    Abstract available



  89. AMADO LA , Villar LM, de Paula VS, Pinto MA, et al
    Exposure to multiple subgenotypes of hepatitis a virus during an outbreak using matched serum and saliva specimens.
    J Med Virol. 2011;83:768-75.
    PubMed     Text format     Related articles    Abstract available



  90. SAKAMOTO N , Nakagawa M, Tanaka Y, Sekine-Osajima Y, et al
    Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b.
    J Med Virol. 2011;83:871-8.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  91. FIORAVANTI J , Gomar C, Medina-Echeverz J, Otano I, et al
    Characterization of woodchuck apolipoprotein A-I: A new tool for drug delivery and identification of altered isoforms in the woodchuck chronic hepatitis model.
    J Med Virol. 2011 Apr 22. doi: 10.1002/jmv.22104.
    PubMed     Text format     Related articles   



  92. MARTIN CM , Welge JA, Blackard JT
    Hepatitis B virus (HBV) X gene diversity and evidence of recombination in HBV/HIV co-infected persons.
    J Med Virol. 2011 Apr 22. doi: 10.1002/jmv.22090.
    PubMed     Text format     Related articles   



  93. CAO J , Bi S, Meng Q, Shen L, et al
    Genotyping of acute hepatitis a virus isolates from China, 2003-2008.
    J Med Virol. 2011 Apr 22. doi: 10.1002/jmv.22086.
    PubMed     Text format     Related articles   



  94. AAKANKSHA , Asim M, Sharma PK, Das BC, et al
    Analysis of carriers of hepatitis B virus from a tertiary referral hospital: Does the viral load change during the natural course of infection?
    J Med Virol. 2011 Apr 22. doi: 10.1002/jmv.22074.
    PubMed     Text format     Related articles   



  95. OPALEYE OO , Fagbami AH, Lalremruata A, Kun JF, et al
    Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.
    J Med Virol. 2011;83:710-6.
    PubMed     Text format     Related articles    Abstract available



  96. KHAN A , Tanaka Y, Kurbanov F, Elkady A, et al
    Investigating an outbreak of acute viral hepatitis caused by hepatitis E virus variants in Karachi, South Pakistan.
    J Med Virol. 2011;83:622-9.
    PubMed     Text format     Related articles    Abstract available



  97. HE Y , Zhang J, Zhong L, Chen X, et al
    Prevalence of and risk factors for hepatitis C virus infection among blood donors in Chengdu, China.
    J Med Virol. 2011;83:616-21.
    PubMed     Text format     Related articles    Abstract available



  98. CALADO RA , Rocha MR, Parreira R, Piedade J, et al
    Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal.
    J Med Virol. 2011;83:608-15.
    PubMed     Text format     Related articles    Abstract available



  99. CHENG PN , Liu WC, Tsai HW, Wu IC, et al
    Association of intrahepatic cccDNA reduction with the improvement of liver histology in chronic hepatitis B patients receiving oral antiviral agents.
    J Med Virol. 2011;83:602-7.
    PubMed     Text format     Related articles    Abstract available



  100. CHOOK JB , Ngeow YF, Yap SF, Tan TC, et al
    Combined use of wild-type HBV precore and high serum iron marker as a potential tool for the prediction of cirrhosis in chronic Hepatitis B infection.
    J Med Virol. 2011;83:594-601.
    PubMed     Text format     Related articles    Abstract available



  101. TATEMATSU K , Tanaka Y, Sugiyama M, Sudoh M, et al
    Host sphingolipid biosynthesis is a promising therapeutic target for the inhibition of hepatitis B virus replication.
    J Med Virol. 2011;83:587-93.
    PubMed     Text format     Related articles    Abstract available



  102. NEIBECKER M , Schwarze-Zander C, Rockstroh JK, Spengler U, et al
    Evidence for extensive genotypic diversity and recombination of GB virus C (GBV-C) in Germany.
    J Med Virol. 2011;83:685-94.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  103. KUROSAKI M , Sakamoto N, Iwasaki M, Sakamoto M, et al
    Sequences in the interferon sensitivity-determining region and core region of hepatitis C virus impact pretreatment prediction of response to PEG-interferon plus ribavirin: Data mining analysis.
    J Med Virol. 2011;83:445-52.
    PubMed     Text format     Related articles    Abstract available



  104. NICOT F , Alric L, Barange K, Metivier S, et al
    Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy.
    J Med Virol. 2011;83:437-44.
    PubMed     Text format     Related articles    Abstract available



  105. DENCS A , Hettmann A, Martyin T, Jekkel C, et al
    Phylogenetic investigation of nosocomial transmission of hepatitis C virus in an oncology ward.
    J Med Virol. 2011;83:428-36.
    PubMed     Text format     Related articles    Abstract available



  106. INOUE Y , Hiramatsu N, Oze T, Yakushijin T, et al
    Amino acid substitution in the core protein has no impact on relapse in hepatitis C genotype 1 patients treated with peginterferon and ribavirin.
    J Med Virol. 2011;83:419-27.
    PubMed     Text format     Related articles    Abstract available



  107. SUGAUCHI F , Tanaka Y, Kusumoto S, Matsuura K, et al
    Virological and clinical characteristics on reactivation of occult hepatitis B in patients with hematological malignancy.
    J Med Virol. 2011;83:412-8.
    PubMed     Text format     Related articles    Abstract available



  108. LEE SA , Cho YK, Lee KH, Hwang ES, et al
    Gender disparity in distribution of the major hydrophilic region variants of hepatitis B virus genotype C according to hepatitis B e antigen serostatus.
    J Med Virol. 2011;83:405-11.
    PubMed     Text format     Related articles    Abstract available



  109. NGUYEN CH , Ishizaki A, Chung PT, Hoang HT, et al
    Prevalence of HBV infection among different HIV-risk groups in Hai Phong, Vietnam.
    J Med Virol. 2011;83:399-404.
    PubMed     Text format     Related articles   



    February 2011
  110. MU SC , Wang GM, Jow GM, Chen BF, et al
    Impact of universal vaccination on intrafamilial transmission of hepatitis B virus.
    J Med Virol. 2011 Feb 25. doi: 10.1002/jmv.22055.
    PubMed     Text format     Related articles    Abstract available



  111. SHAO ZJ , Zhang L, Xu JQ, Xu DZ, et al
    Mother-to-infant transmission of hepatitis B virus: A chinese experience.
    J Med Virol. 2011 Feb 25. doi: 10.1002/jmv.22043.
    PubMed     Text format     Related articles    Abstract available



  112. MA H , Song X, Harrison TJ, Zhang H, et al
    Hepatitis E virus ORF3 antigens derived from genotype 1 and 4 viruses are detected with varying efficiencies by an anti-hev enzyme immunoassay.
    J Med Virol. 2011 Feb 25. doi: 10.1002/jmv.22032.
    PubMed     Text format     Related articles    Abstract available



  113. XIE Y , Ruan B, Chen Y, Wu N, et al
    Kaposi's sarcoma-associated herpesvirus infection in Chinese patients with chronic hepatitis B.
    J Med Virol. 2011 Feb 25. doi: 10.1002/jmv.22001.
    PubMed     Text format     Related articles    Abstract available



  114. ABREHA T , Woldeamanuel Y, Pietsch C, Maier M, et al
    Genotypes and viral load of hepatitis C virus among persons attending a voluntary counseling and testing center in Ethiopia.
    J Med Virol. 2011 Feb 23. doi: 10.1002/jmv.21788.
    PubMed     Text format     Related articles    Abstract available



  115. FARAG NH , Rashed HA, Hassan M, Darweesh A, et al
    Hepatitis C infection, Cognition, and inflammation in an Egyptian sample.
    J Med Virol. 2011;83:261-6.
    PubMed     Text format     Related articles    Abstract available



  116. BISWAS A , Banerjee A, Chandra PK, Datta S, et al
    Variations in the functional domain of basal core promoter of hepatitis B virus among Eastern Indian patients with prevalence of genotypes A, C, and D among the same ethnic population.
    J Med Virol. 2011;83:253-60.
    PubMed     Text format     Related articles    Abstract available



  117. ASIMINA F , Dimitrios P, Maria D, Mathaios M, et al
    Molecular epidemiology of chronic hepatitis B virus infection in Greece.
    J Med Virol. 2011;83:245-52.
    PubMed     Text format     Related articles    Abstract available



  118. GULUBE Z , Chirara M, Kew M, Tanaka Y, et al
    Molecular characterization of hepatitis B virus isolates from Zimbabwean blood donors.
    J Med Virol. 2011;83:235-44.
    PubMed     Text format     Related articles    Abstract available



  119. UTSUMI T , Nugrahaputra VE, Amin M, Hayashi Y, et al
    Another novel subgenotype of hepatitis B virus genotype C from papuans of Highland origin.
    J Med Virol. 2011;83:225-34.
    PubMed     Text format     Related articles    Abstract available



  120. YANG L , Ma S, Hu X, Xiao L, et al
    Presence of valine at position 27 of the hepatitis B virus core gene is associated with severe liver inflammation in Chinese patients.
    J Med Virol. 2011;83:218-24.
    PubMed     Text format     Related articles    Abstract available



  121. MELGACO JG , Pinto MA, Rocha AM, Freire M, et al
    The use of dried blood spots for assessing antibody response to hepatitis A virus after natural infection and vaccination.
    J Med Virol. 2011;83:208-17.
    PubMed     Text format     Related articles    Abstract available



  122. FUJIWARA K , Kojima H, Yasui S, Okitsu K, et al
    Hepatitis A viral load in relation to severity of the infection.
    J Med Virol. 2011;83:201-7.
    PubMed     Text format     Related articles    Abstract available



  123. TSAI CF , Lin DB, Chen SC, Chang YH, et al
    Seroepidemiology of hepatitis A virus infection among schoolchildren in Taiwan.
    J Med Virol. 2011;83:196-200.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  124. TOYODA H , Kumada T, Kiriyama S, Tanikawa M, et al
    Outcome in partial early virologic responders to combination therapy with peginterferon and ribavirin in patients infected with hepatitis C virus genotype 1b.
    J Med Virol. 2011;83:101-7.
    PubMed     Text format     Related articles    Abstract available



  125. AVELLON A , Echevarria JM, Weber B, Weik M, et al
    European collaborative evaluation of the enzygnost HBsAg 6.0 assay: Performance on hepatitis B virus surface antigen variants.
    J Med Virol. 2011;83:95-100.
    PubMed     Text format     Related articles    Abstract available



  126. SONG EY , Shin Y, Roh EY, Sue S, et al
    Serum HBsAg levels during peginterferon alpha-2a treatment with or without thymosin alpha-1 in HBeAg-positive chronic hepatitis B patients.
    J Med Virol. 2011;83:88-94.
    PubMed     Text format     Related articles    Abstract available



  127. YAO X , Wang XY, Zhao C, Sun SH, et al
    Transcriptional analysis of immune-related genes in dendritic cells from hepatitis B surface antigen (HBsAg)-positive transgenic mice and regulation of Fc gamma receptor IIB by HBsAg-anti-HBs complex.
    J Med Virol. 2011;83:78-87.
    PubMed     Text format     Related articles    Abstract available



  128. MOTA A , Areias J, Cardoso MF
    Chronic liver disease and cirrhosis among patients with hepatitis B virus infection in northern Portugal with reference to the viral genotypes.
    J Med Virol. 2011;83:71-7.
    PubMed     Text format     Related articles    Abstract available



  129. LEE SA , Mun HS, Kim H, Lee HK, et al
    Naturally occurring hepatitis B virus X deletions and insertions among Korean chronic patients.
    J Med Virol. 2011;83:65-70.
    PubMed     Text format     Related articles    Abstract available



  130. DEPAMEDE SN , Wahyono A, Nagashima S, Takahashi M, et al
    Analysis of the full-length genomes of novel hepatitis B virus subgenotypes C11 and C12 in Papua, Indonesia.
    J Med Virol. 2011;83:54-64.
    PubMed     Text format     Related articles    Abstract available



  131. LIU S , Xie J, Yin J, Zhang H, et al
    A matched case-control study of hepatitis B virus mutations in the preS and core promoter regions associated independently with hepatocellular carcinoma.
    J Med Virol. 2011;83:45-53.
    PubMed     Text format     Related articles    Abstract available



  132. D'UGO E , Canitano A, Catone S, Giuseppetti R, et al
    Effect of an immunogenic complex containing WHV viral particles and non-neutralizing anti-HBs antibodies on the outcome of WHV infection in woodchucks.
    J Med Virol. 2011;83:178-86.
    PubMed     Text format     Related articles    Abstract available



  133. BHANICH SUPAPOL W , Remis RS, Raboud J, Millson M, et al
    Prevalence and correlates of GB virus C infection in HIV-infected and HIV-uninfected pregnant women in Bangkok, Thailand.
    J Med Virol. 2011;83:33-44.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  134. SHIMOZUMA Y , Ito T, Inokuchi M, Uchikoshi M, et al
    Reactivation of epstein-barr virus in B cells of patients with chronic hepatitis C.
    J Med Virol. 2010;82:2064-72.
    PubMed     Text format     Related articles    Abstract available



  135. SHIMOZUMA Y , Ito T, Inokuchi M, Uchikoshi M, et al
    Reactivation of epstein-barr virus in B cells of patients with chronic hepatitis C.
    J Med Virol. 2010;82:2064-72.
    PubMed     Text format     Related articles    Abstract available



  136. NATARAJAN V , Kottilil S, Hazen A, Adelsberger J, et al
    HCV in peripheral blood mononuclear cells are predominantly carried on the surface of cells in HIV/HCV co-infected individuals.
    J Med Virol. 2010;82:2032-7.
    PubMed     Text format     Related articles    Abstract available



  137. HALFON P , Perusat S, Bourliere M, Bronowicki JP, et al
    Neutralizing antibodies to interferon-alpha and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-alpha-2a and ribavirin (ANRS HC16 GAMMATRI substudy*).
    J Med Virol. 2010;82:2027-2031.
    PubMed     Text format     Related articles    Abstract available



  138. CHEN JY , Chen WN, Liu LL, Lin WS, et al
    Hepatitis B spliced protein (HBSP) generated by a spliced hepatitis B virus RNA participates in abnormality of fibrin formation and functions by binding to fibrinogen gamma chain.
    J Med Virol. 2010;82:2019-26.
    PubMed     Text format     Related articles    Abstract available



    November 2010
  139. TURNER J , Godkin A, Neville P, Kingham J, et al
    Clinical characteristics of hepatitis E in a "Non-Endemic" population.
    J Med Virol. 2010;82:1899-902.
    PubMed     Text format     Related articles    Abstract available



  140. MORA MV , Romano CM, Gomes-Gouvea MS, Gutierrez MF, et al
    Molecular characterization, distribution, and dynamics of hepatitis C virus genotypes in blood donors in Colombia.
    J Med Virol. 2010;82:1889-98.
    PubMed     Text format     Related articles    Abstract available



  141. ELKADY A , Tanaka Y, Kurbanov F, Sugauchi F, et al
    Performance of two Real-Time RT-PCR assays for quantitation of hepatitis C virus RNA: evaluation on HCV genotypes 1-4.
    J Med Virol. 2010;82:1878-88.
    PubMed     Text format     Related articles    Abstract available



  142. ERIKSEN MB , Jorgensen LB, Krarup H, Laursen AL, et al
    Molecular and epidemiological profiles of hepatitis C virus genotype 4 in Denmark.
    J Med Virol. 2010;82:1869-77.
    PubMed     Text format     Related articles    Abstract available



  143. ASKAR E , Ramadori G, Mihm S
    Toll-like receptor 7 rs179008/Gln11Leu gene variants in chronic hepatitis C virus infection.
    J Med Virol. 2010;82:1859-68.
    PubMed     Text format     Related articles    Abstract available



  144. DAMEROW H , Yuen L, Wiegand J, Walker C, et al
    Mutation pattern of lamivudine resistance in relation to hepatitis B genotypes: hepatitis B genotypes differ in their lamivudine resistance associated mutation pattern.
    J Med Virol. 2010;82:1850-8.
    PubMed     Text format     Related articles    Abstract available



  145. YEUNG P , Wong DK, Lai CL, Fung J, et al
    Profile of pre-S deletions in the natural history of chronic hepatitis B infection.
    J Med Virol. 2010;82:1843-9.
    PubMed     Text format     Related articles    Abstract available



  146. RYU HJ , Lee JM, Ahn SH, Kim do Y, et al
    Efficacy of adefovir add-on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine-resistant chronic hepatitis B.
    J Med Virol. 2010;82:1835-42.
    PubMed     Text format     Related articles    Abstract available



  147. SULBARAN Y , Gutierrez CR, Marquez B, Rojas D, et al
    Hepatitis A virus genetic diversity in Venezuela: exclusive circulation of subgenotype IA and evidence of quasispecies distribution in the isolates.
    J Med Virol. 2010;82:1829-34.
    PubMed     Text format     Related articles    Abstract available



    October 2010
  148. LINDEMANN ML , Gabilondo G, Romero B, de la Maza OM, et al
    Low prevalence of hepatitis E infection among pregnant women in Madrid, Spain.
    J Med Virol. 2010;82:1666-8.
    PubMed     Text format     Related articles    Abstract available



  149. EL-ATTAR LM , Partidos CD, Howard CR
    A peptide mimotope of hepatitis C virus E2 protein is immunogenic in mice and block human anti-HCV sera.
    J Med Virol. 2010;82:1655-65.
    PubMed     Text format     Related articles    Abstract available



  150. LARSEN C , Bousquet V, Delarocque-Astagneau E, Pioche C, et al
    Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in France.
    J Med Virol. 2010;82:1647-1654.
    PubMed     Text format     Related articles    Abstract available



  151. FRANCOIS C , Descamps V, Brochot E, Bernard I, et al
    Relationship between the hepatitis C viral load and the serum interferon concentration during the first week of peginterferon-alpha-2b-ribavirin combination therapy.
    J Med Virol. 2010;82:1640-6.
    PubMed     Text format     Related articles    Abstract available



  152. MOSSNER BK , Skamling M, Jorgensen TR, Georgsen J, et al
    Decline in hepatitis B infection observed after 11 years of regional vaccination among Danish drug users.
    J Med Virol. 2010;82:1635-9.
    PubMed     Text format     Related articles    Abstract available



  153. BOVIER PA , Bock J, Ebengo TF, Frosner G, et al
    Predicted 30-year protection after vaccination with an aluminum-free virosomal hepatitis A vaccine.
    J Med Virol. 2010;82:1629-34.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  154. MESCHI S , Schepisi MS, Nicastri E, Bevilacqua N, et al
    The prevalence of antibodies to human herpesvirus 8 and hepatitis B virus in patients in two hospitals in Tanzania.
    J Med Virol. 2010;82:1569-75.
    PubMed     Text format     Related articles    Abstract available



  155. CASTILLO I , Bartolome J, Quiroga JA, Barril G, et al
    Diagnosis of occult hepatitis C without the need for a liver biopsy.
    J Med Virol. 2010;82:1554-9.
    PubMed     Text format     Related articles    Abstract available



  156. SATOH K , Takahashi H, Matsuda C, Tanaka T, et al
    Natural killer cells target HCV core proteins during the innate immune response in HCV transgenic mice.
    J Med Virol. 2010;82:1545-53.
    PubMed     Text format     Related articles    Abstract available



  157. TOYODA H , Kumada T, Kiriyama S, Tanikawa M, et al
    An early viral response to standard interferon-alpha identifies resistance to combination therapy with peginterferon and ribavirin in patients infected by HCV genotype 1.
    J Med Virol. 2010;82:1537-44.
    PubMed     Text format     Related articles    Abstract available



  158. ROMAN S , Tanaka Y, Khan A, Kurbanov F, et al
    Occult hepatitis B in the genotype H-infected Nahuas and Huichol native Mexican population.
    J Med Virol. 2010;82:1527-36.
    PubMed     Text format     Related articles    Abstract available



  159. DUPINAY T , Restorp K, Leutscher P, Rousset D, et al
    High prevalence of hepatitis B virus genotype E in Northern Madagascar indicates a West-African lineage.
    J Med Virol. 2010;82:1515-26.
    PubMed     Text format     Related articles    Abstract available



  160. MA J , Guo X, Wu X, Li J, et al
    Association of NKG2D genetic polymorphism with susceptibility to chronic hepatitis B in a Han Chinese population.
    J Med Virol. 2010;82:1501-7.
    PubMed     Text format     Related articles    Abstract available



  161. LIN LY , Wong VW, Zhou HJ, Chan HY, et al
    Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg-negative patients.
    J Med Virol. 2010;82:1494-500.
    PubMed     Text format     Related articles    Abstract available



  162. MENDES-CORREA MC , Pinho JR, Locarnini S, Yuen L, et al
    High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B.
    J Med Virol. 2010;82:1481-8.
    PubMed     Text format     Related articles    Abstract available



  163. KANG SY , Kim MH, Lee WI
    The prevalence of "anti-HBc alone" and HBV DNA detection among anti-HBc alone in Korea.
    J Med Virol. 2010;82:1508-14.
    PubMed     Text format     Related articles    Abstract available



  164. HANN HW , Dunn SR, Ahn M, Park SY, et al
    Question of ALT flare during switch to adefovir from lamivudine: A single center open-label, randomized, safety study (June 17, 2005 to February 5, 2009).
    J Med Virol. 2010;82:1489-93.
    PubMed     Text format     Related articles    Abstract available



    June 2010
  165. SEREMBA E , Ocama P, Opio CK, Kagimu M, et al
    Validity of the rapid strip assay test for detecting HBsAg in patients admitted to hospital in Uganda.
    J Med Virol. 2010;82:1334-1340.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: